A Systematic Comparison of Microsimulation Models of Colorectal Cancer

Background. As the complexity of microsimulation models increases, concerns about model transparency are heightened. Methods. The authors conducted model “experiments” to explore the impact of variations in “deep” model parameters using 3 colorectal cancer (CRC) models. All natural history models were calibrated to match observed data on adenoma prevalence and cancer incidence but varied in their underlying specification of the adenocarcinoma process. The authors projected CRC incidence among individuals with an underlying adenoma or preclinical cancer v. those without any underlying condition and examined the impact of removing adenomas. They calculated the percentage of simulated CRC cases arising from adenomas that developed within 10 or 20 years prior to cancer diagnosis and estimated dwell time—defined as the time from the development of an adenoma to symptom-detected cancer in the absence of screening among individuals with a CRC diagnosis. Results. The 20-year CRC incidence among 55-year-old individuals with an adenoma or preclinical cancer was 7 to 75 times greater than in the condition-free group. The removal of all adenomas among the subgroup with an underlying adenoma or cancer resulted in a reduction of 30% to 89% in cumulative incidence. Among CRCs diagnosed at age 65 years, the proportion arising from adenomas formed within 10 years ranged between 4% and 67%. The mean dwell time varied from 10.6 to 25.8 years. Conclusions. Models that all match observed data on adenoma prevalence and cancer incidence can produce quite different dwell times and very different answers with respect to the effectiveness of interventions. When conducting applied analyses to inform policy, using multiple models provides a sensitivity analysis on key (unobserved) “deep” model parameters and can provide guidance about specific areas in need of additional research and validation.

[1]  U. P. S. T. Force,et al.  Screening for Colorectal Cancer: Recommendation and Rationale , 2002, Annals of Internal Medicine.

[2]  S. Winawer,et al.  Screening for colorectal cancer in a high-risk population. Results of a mathematical model. , 1987, Gastroenterology.

[3]  S Kamen,et al.  The task force. , 1976, Journal of hospital dental practice.

[4]  J. Bombí,et al.  Polyps of the colon in barcelona, Spain. An autopsy study , 1988, Cancer.

[5]  P. J. Young,et al.  Predictors of presence, multiplicity, size and dysplasia of colorectal adenomas. A necropsy study in New Zealand. , 1992, Gut.

[6]  T C ARMINSKI,et al.  Incidence and distribution of adenomatous polyps of the colon and rectum based on 1,000 autopsy examinations , 1964, Diseases of the colon and rectum.

[7]  Robert J. Mayer,et al.  Erratum: Colorectal cancer screening: Clinical guidelines and rationale (Gastroenterology (1997) 112 (594-642)) , 1997 .

[8]  P C Prorok,et al.  Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. , 2000, Controlled clinical trials.

[9]  I CHAPMAN,et al.  Adenomatous Polypi of Large Intestine: Incidence and Distribution , 1963, Annals of surgery.

[10]  J W BAKER,et al.  Polyps of the colon. , 1962, Surgery, gynecology & obstetrics.

[11]  Grace Huang,et al.  Aspirin as an Adjunct to Screening for Prevention of Sporadic Colorectal Cancer: A Cost-Effectiveness Analysis , 2001, Annals of Internal Medicine.

[12]  Hermann Brenner,et al.  Cost-effectiveness of colonoscopy in screening for colorectal cancer. , 2002, Archives of internal medicine.

[13]  Graham A. Colditz,et al.  Cost-effectiveness of screening for colorectal cancer in the general population. , 2000, JAMA.

[14]  C. Crosta,et al.  Baseline findings of the Italian multicenter randomized controlled trial of "once-only sigmoidoscopy"--SCORE. , 2002, Journal of the National Cancer Institute.

[15]  Amy B. Knudsen,et al.  Stool DNA Testing to Screen for Colorectal Cancer in the Medicare Population , 2010, Annals of Internal Medicine.

[16]  B. Levin,et al.  Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. , 2008, Gastroenterology.

[17]  L M Schuman,et al.  Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. , 1993, The New England journal of medicine.

[18]  A. Noffsinger Serrated polyps and colorectal cancer: new pathway to malignancy. , 2009, Annual review of pathology.

[19]  C. Johnson,et al.  Cost-effectiveness of double-contrast barium enema in screening for colorectal cancer. , 1998, AJR. American journal of roentgenology.

[20]  T. Church,et al.  The effect of fecal occult-blood screening on the incidence of colorectal cancer. , 2000, The New England journal of medicine.

[21]  C. Mulrow,et al.  Colorectal cancer screening: clinical guidelines and rationale. , 1997, Gastroenterology.

[22]  S. Woolf,et al.  Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence. , 2003, Gastroenterology.

[23]  T. Church,et al.  Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. , 1999, Journal of the National Cancer Institute.

[24]  Michael Pignone,et al.  Cost-effectiveness analyses of colorectal cancer screening: a systematic review for the U.S. Preventive Services Task Force. , 2002, Annals of internal medicine.

[25]  Susan J. Curry,et al.  Fulfilling the Potential of Cancer Prevention and Early Detection , 2003 .

[26]  B. Morson The pathogenesis of colorectal cancer. Introduction. , 1978, Major problems in pathology.

[27]  Michael Pignone,et al.  Workshop Agenda: Economic Models of Colorectal Cancer Screening in Average-Risk Adults , 2005 .

[28]  R. Hayward,et al.  Which colon cancer screening test? A comparison of costs, effectiveness, and compliance. , 2001, The American journal of medicine.

[29]  Amy B. Knudsen,et al.  Cost-effectiveness of computed tomographic colonography screening for colorectal cancer in the medicare population. , 2010, Journal of the National Cancer Institute.

[30]  Robert A Smith,et al.  American Cancer Society Guidelines for the Early Detection of Cancer, 2006 , 2006, CA: a cancer journal for clinicians.

[31]  N. O. Jacobsen,et al.  Polyps of the large intestine in Aarhus, Denmark. An autopsy study. , 1989, Scandinavian journal of gastroenterology.

[32]  Lester J. Blatt,et al.  Polyps of the colon and rectum , 1961 .

[33]  Yrjö Collan,et al.  Prevalence of polyps in an autopsy series from areas with varying incidence of large‐bowel cancer , 1985, International journal of cancer.

[34]  P. Maisonneuve,et al.  Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps. , 2008, Gastroenterology.

[35]  J. Olsen,et al.  Randomised study of screening for colorectal cancer with faecal-occult-blood test , 1996, The Lancet.

[36]  David K Whynes,et al.  Cost-Effectiveness of Screening for Colorectal Cancer: Evidence from the Nottingham Faecal Occult Blood Trial , 2004, Journal of medical screening.

[37]  A. Joseph,et al.  Cost effectiveness of HemoQuant versus hemoccult for colorectal cancer screening , 1988, Journal of General Internal Medicine.

[38]  M. Vatn,et al.  The prevalence of polyps of the large intestine in Oslo: An autopsy study , 1982, Cancer.

[39]  E. C. Hammond,et al.  Adenomatous lesions of the large bowel: An autopsy survey , 1979, Cancer.

[40]  Bernadette Mazurek Melnyk,et al.  Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. , 2008, Annals of internal medicine.

[41]  Carolyn M. Rutter,et al.  Clarifying Differences in Natural History between Models of Screening , 2011, Medical decision making : an international journal of the Society for Medical Decision Making.

[42]  Rob Boer,et al.  The MISCAN-COLON Simulation Model for the Evaluation of Colorectal Cancer Screening , 1999, Comput. Biomed. Res..

[43]  B. Levin,et al.  American Cancer Society Guidelines for the Early Detection of Cancer , 2002, CA: a cancer journal for clinicians.

[44]  B. Morson The pathogenesis of colorectal cancer , 1978 .

[45]  Cancer,et al.  Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial , 2010, The Lancet.

[46]  Amy B. Knudsen,et al.  Evaluating Test Strategies for Colorectal Cancer Screening: A Decision Analysis for the U.S. Preventive Services Task Force , 2008, Annals of Internal Medicine.

[47]  D W Day,et al.  Polyps and cancer of the large bowel: a necropsy study in Liverpool. , 1982, Gut.

[48]  Robert W. Klein,et al.  Cost-utility of one-time colonoscopic screening for colorectal cancer at various ages , 2000 .

[49]  M. Bretthauer,et al.  Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: randomised controlled trial , 2009, BMJ : British Medical Journal.

[50]  J. Wagner,et al.  Cost effectiveness of colorectal cancer screening in the elderly. , 1991, Annals of internal medicine.

[51]  J. Mitchell,et al.  A DECISION MODEL AND COST-EFFECTIVENESS ANALYSIS OF COLORECTAL CANCER SCREENING AND SURVEILLANCE GUIDELINES FOR AVERAGE-RISK ADULTS , 2000, International Journal of Technology Assessment in Health Care.

[52]  S. Moss,et al.  Randomised controlled trial of faecal-occult-blood screening for colorectal cancer , 1989, The Lancet.